Divgi CR - Search Results

1

Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer.

Ciunci CA, Perini RF, Avadhani AN, Kang HC, Sun W, Redlinger M, Harlacker K, Flaherty KT, Giantonio BJ, Rosen MA, Divgi CR, Song HK, Englander S, Troxel A, Schnall M, O'Dwyer PJ. Ciunci CA, et al. Among authors: divgi cr. Cancer. 2014 Jan 1;120(1):77-85. doi: 10.1002/cncr.28294. Epub 2013 Sep 24. Cancer. 2014. PMID: 24108668 Free article. Clinical Trial.

2

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

Morris MJ, Pandit-Taskar N, Divgi CR, Bender S, O'Donoghue JA, Nacca A, Smith-Jones P, Schwartz L, Slovin S, Finn R, Larson S, Scher HI. Morris MJ, et al. Among authors: divgi cr. Clin Cancer Res. 2007 May 1;13(9):2707-13. doi: 10.1158/1078-0432.CCR-06-2935. Clin Cancer Res. 2007. PMID: 17473203 Clinical Trial.

3

Non-invasive assessment of tumor neovasculature: techniques and clinical applications.

Perini R, Choe R, Yodh AG, Sehgal C, Divgi CR, Rosen MA. Perini R, et al. Among authors: divgi cr. Cancer Metastasis Rev. 2008 Dec;27(4):615-30. doi: 10.1007/s10555-008-9147-6. Cancer Metastasis Rev. 2008. PMID: 18506398 Review.

4

Molecular imaging of renal cell carcinoma.

Perini R, Pryma D, Divgi C. Perini R, et al. Urol Clin North Am. 2008 Nov;35(4):605-11; vi. doi: 10.1016/j.ucl.2008.07.015. Urol Clin North Am. 2008. PMID: 18992614 Review.

5

Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients.

Lin LL, Silvoniemi A, Stubbs JB, Rengan R, Suilamo S, Solin O, Divgi C, Eskola O, Sorger JM, Stabin MG, Kachur A, Hahn SM, Grönroos TJ, Forsback S, Evans SM, Koch CJ, Minn H. Lin LL, et al. Cancer Biother Radiopharm. 2012 Sep;27(7):412-9. doi: 10.1089/cbr.2011.1130. Epub 2012 Aug 16. Cancer Biother Radiopharm. 2012. PMID: 22897720

6

Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.

Li C, Chacko AM, Hu J, Hasegawa K, Swails J, Grasso L, El-Deiry WS, Nicolaides N, Muzykantov VR, Divgi CR, Coukos G. Li C, et al. Among authors: divgi cr. Cancer Biol Ther. 2014 Apr;15(4):443-51. doi: 10.4161/cbt.27825. Epub 2014 Feb 19. Cancer Biol Ther. 2014. PMID: 24553243 Free PMC article.

7

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma.

Divgi CR, Welt S, Kris M, Real FX, Yeh SD, Gralla R, Merchant B, Schweighart S, Unger M, Larson SM, et al. Divgi CR, et al. J Natl Cancer Inst. 1991 Jan 16;83(2):97-104. doi: 10.1093/jnci/83.2.97. J Natl Cancer Inst. 1991. PMID: 1988695

8

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.

Welt S, Divgi CR, Kemeny N, Finn RD, Scott AM, Graham M, Germain JS, Richards EC, Larson SM, Oettgen HF, et al. Welt S, et al. Among authors: divgi cr. J Clin Oncol. 1994 Aug;12(8):1561-71. doi: 10.1200/JCO.1994.12.8.1561. J Clin Oncol. 1994. PMID: 8040668 Clinical Trial.

9

Overview of clinical radioimmunodetection of human tumors.

Larson SM, Divgi CR, Scott AM. Larson SM, et al. Among authors: divgi cr. Cancer. 1994 Feb 1;73(3 Suppl):832-5. doi: 10.1002/1097-0142(19940201)73:3+<832::aid-cncr2820731313>3.0.co;2-x. Cancer. 1994. PMID: 8306267 Review.

10

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.

Welt S, Scott AM, Divgi CR, Kemeny NE, Finn RD, Daghighian F, Germain JS, Richards EC, Larson SM, Old LJ. Welt S, et al. Among authors: divgi cr. J Clin Oncol. 1996 Jun;14(6):1787-97. doi: 10.1200/JCO.1996.14.6.1787. J Clin Oncol. 1996. PMID: 8656247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page